Oxaliplatin-mediated autoimmune thrombocytopenia

Clinical Colorectal Cancer

Volumn 8, Issue 1, 2009, Pages 61-62

  Saif, Muhammad Wasif ^a   Ledbetter, Leslie ^b  

^a YALE CANCER CENTER   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Bleeding; Chemotherapy; Immune thrombocytopenia; Platelet antibodies

Indexed keywords

BEVACIZUMAB; CAPECITABINE; FLUOROURACIL; FOLINIC ACID; IMMUNOGLOBULIN G; OXALIPLATIN; THROMBOCYTE ANTIBODY;

ADULT; ANEMIA; ANTIBODY DETECTION; AUTOIMMUNE DISEASE; BLEEDING; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; COLON CANCER; DRUG INDUCED DISEASE; DRUG SUBSTITUTION; FEMALE; FLOW CYTOMETRY; HEMATOCRIT; HEMATOLOGICAL PARAMETERS; HUMAN; LETTER; LEUKOCYTE COUNT; LEUKOPENIA; METASTASIS; MULTIPLE CYCLE TREATMENT; NEUROTOXICITY; SIDE EFFECT; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 61349130602     PISSN: 15330028     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1533-0028(11)70349-8     Document Type: Letter

References (23)

1. Aster RH. Drug-induced immune thrombocytopenia: an overview of pathogenesis. Semin Hematol 1999; 36:2-10.
2. Aster RH. Drug-induced thrombocytopenia. In: Platelets. Michelson AD, Ed. New York, NY: Academic Press; 2002:593-606.
3. Curtis BR, Kaliszewski J, Marques MB, et al. Immune-mediated thrombocytope-nia resulting from sensitivity to oxaliplatin. Am J Hematol 2006; 81:193-8.
4. Curtis BR, McFarland JG, Wu GG, et al. Antibodies associated with sulfonamide-induced immune thrombocytopenia react preferentially with calcium-dependent epitopes on the glycoprotein IIb/IIIa complex. Blood 1994; 84:176-83.
5. Gentilini G, Curtis BR, Aster RH. An antibody from a patient with ranitidine-induced thrombocytopenia recognizes a site on glycoprotein IX that is a favored target for drug-induced antibodies. Blood 1998; 92:2359-65.
6. Visentin JP, Wolfmeyer K, Newman PJ, et al. Detection of drug-dependent platelet reactive antibodies by antigen-capture ELISA and flow cytometry. Transfusion 1990; 30:694-700.
7. Andre T, Boni C, Mounedji-Boudiaf L, et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer (MOSAIC). New Engl J Med2004; 350:2343-51.
8. Saif MW, Kang SP, Chu E. Treatment of metastatic colorectal cancer: from cyto-toxic agents to molecular agents and multitargeted strategies. Oncology (Williston Park) 2006; 20(14 suppl 10):11-9.
9. Graham MA, Lockwood GF, Greenslade D, et al. Clinical pharmacokinetics of oxaliplatin: A critical review. Clin Cancer Res 2000; 6:1205-18.
10. Getaz EP, Beckley S, Fitzpatrick J, et al. Cisplatin-induced hemolysis. N Engl J Med 1980; 302:334-5.
11. Marani TM, Trich MB, Armstrong KS, et al. Carboplatin-induced immune hemo-lytic anemia. Transfusion 1996; 36:1016-8.
12. Desrame J, Broustet H, Darodes de Tailly P, et al. Oxaliplatin-induced haemolytic anaemia. Lancet 1999; 354:1179-80.
13. Chen VM, Thrift KM, Morel-Kopp MC, et al. An immediate hemolytic reaction induced by repeated administration of oxaliplatin. Transfusion 2004; 44:838-43.
14. SorbyeH, Bruserud Y, Dahl O. Oxaliplatin-induced haematological emergency with an immediate severe thromobcytopenia and hemolysis. Acta Oncol 2001; 40:882-3.
15. Earle CC, Chen WY, Ryan DP, et al. Oxaliplatin-induced Evans's syndrome. Br J Cancer 2001; 84:441.
16. Dold FG, Mitchell EP. Sudden-onset thrombocytopenia with oxaliplatin. Ann Intern Med 2003; 139:E156-7.
17. Koutras AK, Makatsoris T, Paliogianni F, et al. Oxaliplatin-induced acute-onset thrombocytopenia, hemorrhage and hemolysis. Oncology 2004; 67:179-82.
18. Garratty G. Immune cytopenia associated with antibiotics. Transfus Med Rev 1993; 7:255-67.
19. Marani TM, Trich MB, Armstrong KS, et al. Laboratory investigation of drug-induced immune thrombocytopenias. Tranfus Med Rev 1993; 8:275-87.
20. Bozec L, Bierling P, Fromont P, et al. Irinotecan-induced immune thrombocyto-penia. Ann Oncol 1998; 9:453-5.
21. Mueller-Eckhardt C, Kuenzlen E, Kiefel V, et al. Cyclophosphamide-induced immune thrombocytopenia in a patient with ovarian carcinoma successfully treated with intravenous gamma globulin. Blut 1983; 46:165-9.
22. Seidman AD, Schwartz M, Reich L, et al. Immune-mediated thrombocytopenia secondary to suramin. Cancer 1993; 71:851-4.
23. Morgan M, Savdie E, Dodds A. Thrombocytopaenia as a complication of cyclo-sporine A therapy. Austr N Zealand J Med 1990; 20:749.